Leveraging AI in early stage drug discovery and due diligence: Autobahn Labs & Causaly webinar

Causaly and Autobahn Labs – an early stage drug discovery incubator launched by Evotec, Samsara Biocapital and KCK – co-hosted a joint webinar on the 29th of June

0 min read
Written by
Yiannis Kiachopoulos
  • Categories
  • Tech
Receive the latest newsletter directly to your inbox
open quotes
Switching over to Causaly has been transformative
close quotes
Dr. Yuxi Lin, Associate Director of Project Management at Autobahn Labs
open quotes
We want comfort in the therapeutic rationale that impacting Protein X will have a beneficial impact on Disease Y. You can do these searches in Google and get an impossible number of hits - but Causaly really allows us to drill down into these relationships and get supporting data for the directionality of the effect.
close quotes
Dr. Tom Novak, CSO at Autobahn Labs

More on Tech